Schedule 13G ownership disclosure

Bicara Therapeutics Inc

Common Stock, $0.0001 par value · CUSIP: 055477103

Event date: 2026-02-05

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deep Track Capital, LP

    Shares: 2,750,000.00 · Class: 5.02%

  • Deep Track Biotechnology Master Fund, Ltd.

    Shares: 2,750,000.00 · Class: 5.02%

  • David Kroin

    Shares: 2,750,000.00 · Class: 5.02%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-26-000689
Form type
SCHEDULE 13G
Filer
Bicara Therapeutics Inc.
CIK
CIK 2023658
Filed
Feb 12, 2026
Reporting period
Feb 05, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub